Jury Returns $20 Million Verdict Against Johnson & Johnson in Ethicon Pelvic Mesh Bellwether Case
A Pennsylvania jury recently returned a $20 million verdict against major household product and medical device maker Johnson & Johnson in a lawsuit regarding its pelvic mesh products. The lawsuit is part of the ongoing pelvic mesh multi-district litigation (MDL), and it constituted the third bellwether trial to proceed. According to some reports, there are over 54,000 additional lawsuits pending against the company, which is the largest health care product manufacturer in the world.
MDLs are similar to class actions in that they involve grouping claims that assert similar factual allegations and legal claims. They are different from class actions, however, in that each plaintiff must still prove his or her damages. In a class action, the entire class is awarded a collective settlement that is then distributed according to amounts and procedures approved by the court. To gauge the legal soundness of the plaintiffs’ claims, bellwether trials are conducted to gauge the likely level of liability and to assess the likely damages award against the defendant. These trials are crucial indicators of how the remaining cases pending in the MDL may play out.
In the most recent case, the plaintiff alleged that she received a TVT-Secur mesh product during a surgical procedure to address her stress urinary incontinence and that the product began to erode after two months. The plaintiff stated in her complaint that she underwent three surgeries to remove the mesh product and that Johnson & Johnson marketed the product despite its risks and without providing warnings about these risks.
Illinois Injury and Mass Tort Lawyer Blog




